Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties

Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant Properties The requirements for tuberculosis screening for certain Phase-I clinical trials in healthy volunteers. 2021-06-02 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetytuberculosis screeningrequirements for tuberculosis screeninghealthy volunteersPhase I clinical trialsimmunosuppressant drugsdrugs with immunosuppressant properties Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant PropertiesHTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/clinical-trials/update-clinical-trial-sponsors-requirements-tuberculosis-screening-healthy-volunteers-phase-1-clinical-trials-involving-immunosuppressant-drugs.html Update: Requirements for Tuberculosis Screening of Healthy Volunteers in Phase I Clinical Trials involving Immunosuppressant Drugs or Drugs with Immunosuppressant PropertiesHTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/essais-cliniques/mise-jour-intention-promoteurs-essais-cliniques-exigences-depistage-tuberculose-chez-volontaires-bonne-sante-cadre-essais-cliniques-phase-1-portant.html

The requirements for tuberculosis screening for certain Phase-I clinical trials in healthy volunteers.

Data and Resources

Similar records